News Focus
News Focus
icon url

DewDiligence

02/16/14 4:04 PM

#174304 RE: DewDiligence #156500

PTLA inks phase-3 clinical collaboration with Bayer/JNJ for Andexanet Alfa (f/k/a PRT4445) as an antidote to Xarelto:

http://finance.yahoo.com/news/portola-pharmaceuticals-enters-clinical-collaboration-130000148.html

This PR (which was issued on 2/3/14) extends the collaboration these companies already had to complete a phase-2 trial (#msg-84232022). As was the case with the phase-2 collaboration, financial terms were not disclosed.